Attenuation of Hyperlipidemia by Medicinal Formulations of Emblica officinalis Synergized with Nanotechnological Approaches.

The ayurvedic herb Emblica officinalis (E. officinalis) is a gift to mankind to acquire a healthy
lifestyle. It has great therapeutic and nutritional importance. Emblica officinalis, also known as Indian
gooseberry or Amla, is a member of the Euphorbiaceae family. Amla is beneficial for treating illnesses
in all its forms. The most crucial component is a fruit, which is also the most common. It is used
frequently in Indian medicine as a restorative, diuretic, liver tonic, refrigerant, stomachic, laxative,
antipyretic, hair tonic, ulcer preventive, and for the common cold and fever. Hyperlipidemia is also
known as high cholesterol or an increase in one or more lipid-containing blood proteins. Various phy�tocompounds, including polyphenols, vitamins, amino acids, fixed oils, and flavonoids, are present
in the various parts of E. officinalis. E. officinalis has been linked to a variety of pharmacological effects
in earlier studies, including hepatoprotective, immunomodulatory, antimicrobial, radioprotective,
and hyperlipidemic effects. The amla-derived active ingredients and food products nevertheless
encounter challenges such as instability and interactions with other food matrices. Considering the
issue from this perspective, food component nanoencapsulation is a young and cutting-edge field
for controlled and targeted delivery with a range of preventative activities. The nanoformulation of
E. officinalis facilitates the release of active components or food ingredients, increased bioaccessibility,
enhanced therapeutic activities, and digestion in the human body. Accordingly, the current review
provides a summary of the phytoconstituents of E. officinalis, pharmacological actions detailing the
plant E. officinalis’s traditional uses, and especially hyperlipidemic activity. Correspondingly, the
article describes the uses of nanotechnology in amla therapeutics and functional ingredients.